OPC-64005

· Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OPC-64005, covering 2021-10-29 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Trial of OPC-64005 for Major Depressive Disorder [Phase 2]